Thomas Soloway
2016
In 2016, Thomas Soloway earned a total compensation of $468.7K as Executive Vice President and Chief Financial Officer at Audentes Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $108,150 |
|---|---|
| Salary | $360,500 |
| Total | $468,650 |
Soloway received $360.5K in salary, accounting for 77% of the total pay in 2016.
Soloway also received $108.2K in non-equity incentive plan.
Rankings
In 2016, Thomas Soloway's compensation ranked 11,403rd out of 14,075 executives tracked by ExecPay. In other words, Soloway earned more than 19.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,403 out of 14,075 | 19th |
Division Manufacturing | 4,444 out of 5,489 | 19th |
Major group Chemicals And Allied Products | 1,593 out of 1,895 | 16th |
Industry group Drugs | 1,288 out of 1,538 | 16th |
Industry Biological Products, Except Diagnostic Substances | 227 out of 279 | 19th |
Source: SEC filing on April 26, 2019.
Soloway's colleagues
We found three more compensation records of executives who worked with Thomas Soloway at Audentes Therapeutics in 2016.